title: Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor.
abstract: Fluorine-18 labeled fluorobutyl[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo [2,3-d] pyrimidin-4-yl]ethylamine (FBPPA) and iodine-123 labeled butyl[2,5-dimethyl-7-(4-iodo-2,6-dimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]ethyl-amine (IBPPA) were synthesized in the development of a CRF receptor ligand. The methods of synthesis, in vitro binding assays, radiolabeling and in vivo tissue distribution in rats are described. Fluorine-18 labeled FBPPA was prepared with high specific activity (3 x 10(4) Ci/mmol) by nucleophilic displacement with an average radiochemical yield of 6% (EOB). Iodine-123 labeled IBPPA was prepared by electrophilic iododestannylation with good yield (60%) and high specific activity (3.3 x 10(3) Ci/mmol). The retention of FBPPA and IBPPA in the pituitary was good (1.16% i.d./g and 2.35% i.d./g respectively at 60 min). However, the accumulation of radioactivity in the brain for both radiotracers was very low at all time points of the study, which demonstrated the difficulties for these radiopharmaceuticals to penetrate the blood brain barrier (BBB).
authors: Department of Radiology, Emory Center for Positron Emission Tomography, Emory University School of Medicine, 1634 Clifton Road N.E., Atlanta, Georgia 30322, USA. lmartar@learnlink.emory.edu
authors: L
authors: L
authors: Martarello
authors: C D
authors: CD
authors: Kilts
authors: T
authors: T
authors: Ely
authors: M J
authors: MJ
authors: Owens
authors: C B
authors: CB
authors: Nemeroff
authors: M
authors: M
authors: Camp
authors: M M
authors: MM
authors: Goodman
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism*; D005462:Fluorine Radioisotopes / Q000493:pharmacokinetics*; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics*; D008024:Ligands; D008297:Male; D010902:Pituitary Gland / Q000378:metabolism; D011743:Pyrimidines / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D011758:Pyrroles / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D011869:Radioligand Assay; D019275:Radiopharmaceuticals / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D051381:Rats; D011916:Rats, Inbred F344; D017207:Rats, Sprague-Dawley; D018019:Receptors, Corticotropin-Releasing Hormone / Q000032:analysis / Q000378:metabolism*; D014018:Tissue Distribution; D014055:Tomography, Emission-Computed; D015899:Tomography, Emission-Computed, Single-Photon; D000099052:CRF Receptor, Type 1
chemical_list: D005462:Fluorine Radioisotopes; D007457:Iodine Radioisotopes; D008024:Ligands; D011743:Pyrimidines; D011758:Pyrroles; D019275:Radiopharmaceuticals; D018019:Receptors, Corticotropin-Releasing Hormone; C431270:butyl(2,5-dimethyl-7-(4-iodo-2,6-dimethylphenyl)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)ethylamine; C431269:fluorobutyl(2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)ethylamine; D000099052:CRF Receptor, Type 1